A detailed history of Credit Agricole S A transactions in Abb Vie Inc. stock. As of the latest transaction made, Credit Agricole S A holds 343,873 shares of ABBV stock, worth $60.8 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
343,873
Previous 268,364 28.14%
Holding current value
$60.8 Million
Previous $46 Million 47.53%
% of portfolio
0.3%
Previous 0.25%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $12.4 Million - $15.1 Million
75,509 Added 28.14%
343,873 $67.9 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $21.1 Million - $24.7 Million
136,561 Added 103.61%
268,364 $46 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $7.28 Million - $8.3 Million
45,573 Added 52.85%
131,803 $24 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $827,526 - $931,989
6,014 Added 7.5%
86,230 $13.4 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $5.31 Million - $6.14 Million
39,714 Added 98.05%
80,216 $12 Million
Q2 2023

Jul 31, 2023

BUY
$132.51 - $164.9 $184,056 - $229,046
1,389 Added 3.55%
40,502 $5.46 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $1.76 Million - $2.03 Million
-12,185 Reduced 23.75%
39,113 $6.23 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $2.46 Million - $2.95 Million
17,761 Added 52.96%
51,298 $8.3 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $576,566 - $661,283
4,296 Added 14.69%
33,537 $4.5 Million
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $607,592 - $772,448
-4,415 Reduced 13.12%
29,241 $4.48 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $3.6 Million - $4.46 Million
27,263 Added 426.45%
33,656 $5.46 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $2.71 Million - $3.43 Million
-25,198 Reduced 79.76%
6,393 $865,000
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $470,500 - $534,089
4,422 Added 16.28%
31,591 $3.41 Million
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $1.98 Million - $2.2 Million
18,790 Added 224.25%
27,169 $3.06 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $403,368 - $444,060
-3,943 Reduced 32.0%
8,379 $907,000
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $47,730 - $64,441
-593 Reduced 4.59%
12,322 $1.32 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $374,481 - $439,517
4,359 Added 50.95%
12,915 $1.13 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $49,818 - $66,664
-679 Reduced 7.35%
8,556 $840,000
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $152,994 - $231,957
2,372 Added 34.56%
9,235 $703,000
Q3 2019

Nov 08, 2019

BUY
$62.98 - $75.72 $432,231 - $519,666
6,863 New
6,863 $519,000
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $346,926 - $385,673
-3,902 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $26,125 - $30,912
-291 Reduced 6.94%
3,902 $361,000
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $5.57 Million - $7.45 Million
-60,504 Reduced 93.52%
4,193 $397,000
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $105 Million - $115 Million
-1,174,645 Reduced 94.78%
64,697 $6.26 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $6.79 Million - $8.68 Million
-97,245 Reduced 7.28%
1,239,342 $110 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,336,587
1,336,587 $96.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.